现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2014年
10期
2349-2351
,共3页
刘佳%任宏%雷光焰%吕卫东%刘志刚
劉佳%任宏%雷光燄%呂衛東%劉誌剛
류가%임굉%뢰광염%려위동%류지강
肺癌%药敏%化疗方案
肺癌%藥敏%化療方案
폐암%약민%화료방안
lung cancer%sensitivity of drug%chemotherapy
目的:研究新鲜肿瘤组织块体外药敏试验和化疗方案以及生存期的关系,指导肺癌术后化疗方案的选择,实现肺癌个体化药物治疗。方法:采用TECIA法对126例肺癌肿瘤新鲜组织标本进行体外培养,选用临床常用的8种化疗药物进行肿瘤药物敏感性试验,根据试验结果选用化疗方案进行术后辅助化疗,并随访观察生存期。结果:126例标本对常见化疗药高度敏感占1.19%,中度敏感占60.71%;根据药敏结果选用中、高度敏感药物进行术后化疗,其5年生存期延长。结论:根据肿瘤药物敏感试验选用化疗药物能延长生存期,对指导患者的个体化治疗具有一定的指导意义。
目的:研究新鮮腫瘤組織塊體外藥敏試驗和化療方案以及生存期的關繫,指導肺癌術後化療方案的選擇,實現肺癌箇體化藥物治療。方法:採用TECIA法對126例肺癌腫瘤新鮮組織標本進行體外培養,選用臨床常用的8種化療藥物進行腫瘤藥物敏感性試驗,根據試驗結果選用化療方案進行術後輔助化療,併隨訪觀察生存期。結果:126例標本對常見化療藥高度敏感佔1.19%,中度敏感佔60.71%;根據藥敏結果選用中、高度敏感藥物進行術後化療,其5年生存期延長。結論:根據腫瘤藥物敏感試驗選用化療藥物能延長生存期,對指導患者的箇體化治療具有一定的指導意義。
목적:연구신선종류조직괴체외약민시험화화료방안이급생존기적관계,지도폐암술후화료방안적선택,실현폐암개체화약물치료。방법:채용TECIA법대126례폐암종류신선조직표본진행체외배양,선용림상상용적8충화료약물진행종류약물민감성시험,근거시험결과선용화료방안진행술후보조화료,병수방관찰생존기。결과:126례표본대상견화료약고도민감점1.19%,중도민감점60.71%;근거약민결과선용중、고도민감약물진행술후화료,기5년생존기연장。결론:근거종류약물민감시험선용화료약물능연장생존기,대지도환자적개체화치료구유일정적지도의의。
Objective:To study the effect of chemosensitivity test in vitro with fresh tumor tissues for lung cancer on chemotherapy and long-term survival. Methods:The sensitivity of 126 lung cancer samples for 8 commonly-used chemotherapeutic drugs was determined by TECIA method,and follow-ups were carried out. Results:Of 126 cases underwent chemosensitivity test with TECIA method,there were 1. 19% very sensitive and 60. 71% moderate sensitive ones. Five-year survivals were extended for those with very sensitive and moderate sensitive cases compared with sensitive resistant ones. Conclusion:The TECIA chemosensitivity test can promote long-term survival of lun-cancer and has potentials to determine the individualized chemotherapy.